Out study is finally out - it didn't feel apropos to tweet this last week with other important matters top of mind. Phase 2 Study Finds Nivolumab-Ipilimumab Combo Shows Activity in Metastatic #UvealMelanoma ascopubs.org/doi/full/10.12… ASCO #JCO

Five years ago today, I started my first patient on a Phase 1 study for #uvealmelanoma . Today, we learned that it improves survival over single agent checkpoint blockade.

Thanks Immunocore and colleagues! So excited to offer this to pts soon! immunocore.com/news/immunocor…

Delighted to present my poster: “Parp inhibition as a possible therapeutic strategy in the treatment of Uveal Melanoma”, at Society Melanoma Res in Edinburgh.
Thanks to my PI Naomi Walsh and to my funding bodies IrishResearchCouncil CCRT

#uvealmelanoma #SMR2022

We received excellent news! #uvealmelanoma

OPEN POSTDOCTORAL POSITION at the Proteases and Extracellular Matrix Group eMatrix_GENYO GENYO #ExtracellularMatrix #ADAMTSproteases #uvealmelanoma 👇👇👇

First case for new UT Southwestern ocular brachytherapy program! ⁦@UTSW_Ophth⁩ ⁦UTSW Simmons Cancer Center⁩ #ocularoncology #uvealmelanoma #retinoblastoma

Proud that our text devoted solely to the science and management of uveal melanoma is finally out ! #UvealMelanoma

Extremely delighted to have been shortlisted for the #IACR2022 poster prize.👩🏻‍🔬👁️
Thank you for your support Breandán Kennedy UCD Breakthrough Cancer Research kayleigh slater 🔬🧬
IrishResearchCouncil Ocular Pharmacology News IACR #research #CancerResearch #UvealMelanoma #Cannabinoid

Honored that my medical school thesis on #BAP1 timing in #uvealmelanoma was featured as a top ocular oncology paper of the year at #AAO2021 ! Grateful for our team Hans Grossniklaus Gustav Stålhammar.

Thanks Mike Zein for sending me this. Hope to be at AAO in person in the future!

Come check out my poster (P-253) about NEW 2D and 3D patients' derived models for #uvealmelanoma #IACR_EACR_AACR_24 !
EACR News IACR AACR

Prof Ramón Alemany from IDIBELL talking about the potential of oncolitic viruses in targeting PD-1/PD-L1 in #uvealmelanoma . Very bad prognosis for uveal melanoma patients that do not get PD-1/PD-L1 treatment. Oncobell Symposium Alvaro Somoza

Delighted to share a little about my #uvealmelanoma research in this Webinar organized by Breakthrough Cancer Research for #OcularMelanoma awareness month 👩🏽‍🔬👩🏽‍💻 Kayleigh Slater Breandán Kennedy UCD 3DNEONET Consortium CRYSTAL3 CONSORTIUM Ocular Pharmacology #OpenYourEyestoUM

Thank you #EADO2024 for highlighting our work in #uvealmelanoma and #tebentafusp , learning from post mortems of our generous patients. Watch this space! 👀🔬

Prof Kennedy explains the unmet need for treatments in #UvealMelanoma , a rare often fatal type of #cancer investigated in #3DNEONET #RareDisease Ocular Pharmacology
Xenopat UCD Conway Institute UCD SBBS MarieSkłodowskaCurie European Research Executive Agency EUScience&Innovation🇪🇺 [email protected]
#H2020 #MSCA #EUFundedResearch

A fantastic #ISOO2022 with lots of interesting presentations on #uvealmelanoma . Great to meet our collaborator Mr. Noel Horgan and so many other uveal melanoma experts in the lovely city of Leiden.
Ocular Pharmacology Breandán Kennedy UCD CRYSTAL3 CONSORTIUM MarieSkłodowskaCurie [email protected] Maria Chiara Gelmi

Recent studies link UV to iris melanoma, a type of uveal melanoma. Protect your eyes 😎 #irismelanoma #UV #uvealmelanoma

Single cell copy-number variation analysis of primary and metastatic uveal melanomas.

Ref: go.nature.com/2RJ0WuN

#singlecell #scRNAseq #uvealmelanoma #copynumbervariation

#UvealMelanoma #ESMO19 'No joined up care' - This kills patients !

Congrats Mathieu Bakhoum and investigators that identified an eye cancer culprit #uvealmelanoma Melanoma Research ophthalmologytimes.com/view/investiga… via Ophthalmology Times

❕Tebentafusp improved OS in Metastatic #UvealMelanoma compared to investigator’s choice in front line setting

❔New standard?

nejm.org/doi/full/10.10…

NEJM #oncology #melanoma